Andere talen Akero Therapeutics, Inc.

Aandelen

AKRO

US00973Y1082

Beurs gesloten - Nasdaq Andere beurzen 22:00:00 24-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
20,26 ^USD	-3,62%		-6,20%	-13,23%

07/03	Akero Therapeutics, Inc. Kondigt de publicatie aan van Fase 2b SYMMETRY Cohort D Studie in Klinische Gastro-enterologie en Hepatologie	CI
07/03	Insider van Akero Therapeutics verkocht aandelen ter waarde van $732.727, volgens een recent SEC-document	MT

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

6 Stocks Positioned to Soar as Investors Focus on MASH	22/04
Pomerantz Law Firm Investigates Claims on Behalf of Investors of Akero Therapeutics, Inc. - AKRO	20/04
Pomerantz Law Firm Investigates Claims on Behalf of Investors of Akero Therapeutics, Inc. - AKRO	05/04
Ademi LLP Investigates Claims of Securities Fraud against Akero Therapeutics, Inc.	03/04
Akero Therapeutics Raises $367 Million From Share Offering	08/03
Akero Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares	08/03
Akero Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares	08/03
Akero Therapeutics Announces Publication of Phase 2b SYMMETRY Cohort D Study in Clinical Gastroenterology and Hepatology	07/03
Akero Therapeutics Announces Publication of Phase 2b SYMMETRY Cohort D Study in Clinical Gastroenterology and Hepatology	07/03
Akero Therapeutics, Inc. Announces Publication of Phase 2b SYMMETRY Cohort D Study in Clinical Gastroenterology and Hepatology	07/03
Akero Therapeutics Insider Sold Shares Worth $732,727, According to a Recent SEC Filing	07/03
Akero Therapeutics Insider Sold Shares Worth $2,465,063, According to a Recent SEC Filing	07/03
Akero Therapeutics Announces Pricing of Public Offering of Common Stock	06/03
Health Care Down on Growth Doubts -- Health Care Roundup	04/03
Akero Therapeutics Proposes $300 Million Common Stock Offering -- Stock Down After Hours	04/03
Akero Therapeutics Announces Proposed Public Offering of Common Stock	04/03
Sector Update: Health Care Stocks Lean Lower Pre-Bell Monday	04/03
Sector Update: Health Care	04/03
US Equity Futures Turn Cautiously Lower Pre-Bell as Investors Eye Powell Testimony	04/03
Exchange-Traded Funds, Equity Futures Mixed Pre-Bell as Traders Hope for Clues to Timing of Rate Cuts	04/03

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Akero Therapeutics, Inc.

Aandelen

AKRO

US00973Y1082

Andere talen

Filters